Europe monoclonal antibodies market was valued at $40.8 billion in 2020 and will grow by 11.0% annually over 2020-2030 owing to the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies. Highlighted with 34 tables and 52 figures, this 110-page report “Europe Monoclonal Antibodies (mAbs) Market 2020-2...
Asia Pacific monoclonal antibodies market will grow by 12.8% annually with a total addressable market cap of $414 billion over 2021-2030 owing to the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies. Highlighted with 31 tables and 51 figures, this 108-page report “Asia Pacific Monoclonal Antibod...
Global Genome Sequencing Market will reach $24.37 billion by 2030, growing by 12.6% annually over 2020-2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine. Highlighted with 82 tables and 85 figures, this 165-page report “Global Genome Sequencing Market 2020-2030 by Product (Consumab...
North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach $10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine. Highlighted with 23 tables and 49 figures, this 103-page report “North America Genome Sequencing Mark...
Europe genome sequencing market was valued at $1,955.5 million in 2020 and will grow by 12.3% annually over 2020-2030 owing to the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine. Highlighted with 33 tables and 53 figures, this 111-page report “Europe Genome Sequencing Market 2020-2030 by Product (...
Asia Pacific genome sequencing market will grow by 15.6% annually with a total addressable market cap of $38.26 billion over 2021-2030 owing to the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine. Highlighted with 30 tables and 52 figures, this 109-page report “Asia Pacific Genome Sequencing Market...
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions. Highlighted with 89 tables and 90 figures, this 180-page report “Global Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer...
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions. Highlighted with 29 tables and 54 figures, this 116-page report “North America Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indi...
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions. Highlighted with 37 tables and 57 figures, this 121-page report “Europe Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimm...
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions. Highlighted with 33 tables and 56 figures, this 116-page report “Asia Pacific Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indi...
